CA
ADAP

Claro Advisors’s Adaptimmune Therapeutics ADAP Stock Holding History

Claro Advisors’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,607
Closed -$35K – 156
2018
Q4 		$35K Buy
+2,607
New +$35K 0.03% 410